Skip to Content
TeamsCtrl Alt WinCommunity Essence Map

🧭 Community Essence Map Ctrl + Alt + Win (MediSure)

Location: Garki, Utako, Nyanya - Abuja, Nigeria
Focus area: Medicine authenticity and pharmaceutical supply chain transparency

Stage 1: Regenerative Exploration


1. Observations from the Community

During our exploration across Garki, Utako, and Nyanya, we noticed that many pharmacies and drug vendors operate in crowded markets with no reliable way for customers to verify the authenticity of medicines.

Patients often buy drugs based on trust, price, or urgency, while street vendors freely sell cheap medicines whose origins are unknown. Pharmacists confirmed that fake anti-malarials and antibiotics frequently enter the market from unregulated distributors, and some private hospitals still lack proper tracking systems.

Many youths and parents expressed concern about “fake drugs everywhere,” but feel powerless to detect them.

Field Observations:

  • Crowded pharmacies with no verification systems visible
  • Street vendors selling medicines from unmarked containers
  • Price-driven purchases overriding safety concerns
  • No digital tools for authenticity checking
  • Suspicious batches arriving without clear documentation
  • Patient helplessness in face of counterfeit risk

2. What We Heard (Quotes)

From Pharmacists:

“We sometimes receive batches that look suspicious, but we can’t verify them.”
— Pharmacist, Utako

“We lose trust when patients come back saying the drugs didn’t work.”
— Clinic Nurse

From Patients:

“I once bought malaria drugs that did nothing.”
— Mother, Nyanya

“If I could just scan and confirm a drug is real, that would save many people.”
— Student, Garki

From Street Vendors:

“People buy from me because it’s cheap. They don’t ask where it comes from.”
— Local Vendor


Observations (what keeps repeating)

  • “I don’t know if this medicine is real”
  • “The drugs didn’t work—my child is still sick”
  • “We receive suspicious batches but have no way to check”
  • “Street drugs are cheaper, so people buy them”
  • “I can’t afford the expensive pharmacy—I buy from roadside”
  • “How do I know where this medicine came from?”
  • “We’ve lost patients’ trust because treatments fail”
  • “If only there was a way to scan and verify”
  • “Fake drugs are everywhere—it’s normal now”

3. Patterns & Themes

Pattern 1: Lack of Verification Tools

Observation:
No easy method to confirm drug authenticity at point of purchase. Even pharmacists cannot verify incoming batches reliably.

Implication:
The absence of simple verification tools creates vulnerability throughout the entire supply chain.

Pattern 2: Weak Supply Chain Transparency

Observation:
Manufacturers, distributors, and pharmacies work in silos with no visibility into each other’s operations.

Implication:
Counterfeit drugs can enter at any point without detection or accountability.

Pattern 3: High Patient Vulnerability

Observation:
People unknowingly buy fake drugs due to cost pressures or urgency, often with no alternative options.

Implication:
The most vulnerable populations bear the highest risk.

Pattern 4: Trust Breakdown

Observation:
Health workers lose credibility because counterfeit drugs make treatments fail, eroding confidence in the entire healthcare system.

Implication:
Even genuine healthcare providers suffer reputation damage from systemic failures beyond their control.

Pattern 5: Unregulated Sellers Rising

Observation:
Street vendors supply fake medicines freely, capitalizing on affordability pressures with no oversight or accountability.

Implication:
The informal economy thrives on the gap between demand for affordable medicine and lack of verification systems.


4. Community Tensions

Affordability vs Safety

People need cheap medicine but cheap medicine is often fake. This creates an impossible choice for low-income families.

Urgency vs Verification

When someone is sick, they buy immediately. There’s no time to verify—leading to quick purchases of potentially fake drugs.

Speed vs Integrity

Pharmacies restock quickly to meet demand, but verification is slow or non-existent—speed wins over safety.

Technology Gap

Pharmacies lack digital tracking tools, creating dependence on paper records and word-of-mouth trust.


5. Community Story (Daily Flow)

Morning:

People buy medicine on their way to work or school—quick purchases, no verification

Afternoon:

Pharmacies restock without transparency—batches arrive, no authentication, straight to shelves

Evening:

Patients take drugs—fake ones lead to persistent symptoms, treatment failures

Long-Term:

Drug resistance increases, healthcare costs rise, trust in medical system declines, preventable deaths continue


6. Themes Summary

  • Verification Crisis: No tools to confirm authenticity
  • Supply Chain Opacity: No visibility from manufacture to patient
  • Vulnerability Exploitation: Poorest communities suffer most
  • Trust Erosion: Healthcare system losing credibility
  • Informal Economy Growth: Street vendors fill the gap dangerously
  • Technology Absence: No digital solutions in widespread use

Essence Summary

People want confidence that their medicine is real. Pharmacists want simple batch verification. Health workers want transparency. The community wants an easy, accessible way to combat counterfeit drugs.

What People Actually Need:

  1. Simple verification—scan a code, get instant confirmation
  2. Transparency—know where the medicine came from
  3. Trust—confidence in the healthcare system
  4. Safety—protection from fake drugs
  5. Affordability without sacrificing authenticity

Final Essence Statement

Abuja residents live with constant uncertainty about the authenticity of their medicines. Despite their best efforts, patients and pharmacists lack simple tools to verify drug origin or quality.

The community is calling for a trustworthy, transparent system that protects their health, restores confidence, and ensures safe access to genuine medication.

MediSure answers this call with blockchain-verified supply chains and instant QR code authentication—putting medicine safety back in the hands of the people.

Last updated on